GB9424674D0 - Polypeptudes which inhibit NADPH oxidase complex - Google Patents

Polypeptudes which inhibit NADPH oxidase complex

Info

Publication number
GB9424674D0
GB9424674D0 GB9424674A GB9424674A GB9424674D0 GB 9424674 D0 GB9424674 D0 GB 9424674D0 GB 9424674 A GB9424674 A GB 9424674A GB 9424674 A GB9424674 A GB 9424674A GB 9424674 D0 GB9424674 D0 GB 9424674D0
Authority
GB
United Kingdom
Prior art keywords
polypeptudes
nadph oxidase
oxidase complex
inhibit nadph
inhibit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9424674A
Other versions
GB2285047B (en
GB2285047A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Astellas Pharma Europe Ltd
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research Ltd
Yamanouchi UK Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939326083A external-priority patent/GB9326083D0/en
Priority claimed from GB9400248A external-priority patent/GB9400248D0/en
Application filed by Ludwig Institute for Cancer Research Ltd, Yamanouchi UK Ltd, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Priority to GB9424674A priority Critical patent/GB2285047B/en
Publication of GB9424674D0 publication Critical patent/GB9424674D0/en
Publication of GB2285047A publication Critical patent/GB2285047A/en
Application granted granted Critical
Publication of GB2285047B publication Critical patent/GB2285047B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GB9424674A 1993-12-21 1994-12-07 Polypeptides which inhibit the NADPH oxidase complex Expired - Fee Related GB2285047B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9424674A GB2285047B (en) 1993-12-21 1994-12-07 Polypeptides which inhibit the NADPH oxidase complex

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939326083A GB9326083D0 (en) 1993-12-21 1993-12-21 Polypeptides which inhibit the nadph oxidase complex
GB9400248A GB9400248D0 (en) 1994-01-07 1994-01-07 Polypeptides which inhibit NADPH oxidise complex
GB9424674A GB2285047B (en) 1993-12-21 1994-12-07 Polypeptides which inhibit the NADPH oxidase complex

Publications (3)

Publication Number Publication Date
GB9424674D0 true GB9424674D0 (en) 1995-02-01
GB2285047A GB2285047A (en) 1995-06-28
GB2285047B GB2285047B (en) 1998-04-15

Family

ID=27266996

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9424674A Expired - Fee Related GB2285047B (en) 1993-12-21 1994-12-07 Polypeptides which inhibit the NADPH oxidase complex

Country Status (1)

Country Link
GB (1) GB2285047B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2311067B (en) * 1996-01-08 2000-03-29 Yamanouchi U K Ltd Proline rich peptides derived from the rasgap-associated protein P62
US6133233A (en) * 1997-02-18 2000-10-17 Kansas State University Research Foundation Peptide modulation of reperfusion injury
US5856139A (en) * 1997-03-11 1999-01-05 Incyte Pharmaceuticals, Inc. Proline-rich acidic protein
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
JP4647871B2 (en) * 1999-12-06 2011-03-09 秀一 廣明 Protein structure coordinates and NMR chemical shifts and their use
US6489149B1 (en) * 2001-03-29 2002-12-03 Pe Corporation (Ny) Isolated human NADPH oxidase, nucleic acid molecules encoding said proteins, and uses thereof
EP1281963A3 (en) * 2001-07-30 2003-03-19 Warner-Lambert Company Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and a SH3 domain comprising peptide
EP1281962A1 (en) * 2001-07-30 2003-02-05 Warner-Lambert Company Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and an SH3 domain comprising peptide
AU2003233147B2 (en) * 2002-05-13 2008-03-06 Arexis Ab Autoimmune conditions and NADPH oxidase defects
EP2752196A1 (en) * 2013-01-03 2014-07-09 Université Bordeaux Segalen Selective nox-1 inhibitor peptides and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244916A (en) * 1992-01-31 1993-09-14 The Scripps Research Institute Inhibition of respiratory burst using posttranslational modification inhibitors

Also Published As

Publication number Publication date
GB2285047B (en) 1998-04-15
GB2285047A (en) 1995-06-28

Similar Documents

Publication Publication Date Title
GB2281910B (en) 3-arylbenzofuranones as stabilisers
HU9600642D0 (en) Enzymatic bleach composition
AU7853194A (en) H2o2-stable peroxidase variants
AU8074694A (en) Keyboard
EP0610714A3 (en) Hard hydrophobic polyurethane.
AU5976394A (en) Oxidising agents
AU7937194A (en) Myxococcaceae peroxidase
GB9424674D0 (en) Polypeptudes which inhibit NADPH oxidase complex
EP0745695A4 (en) Bearing part
GB2274313B (en) Bearings
AU121904S (en) Peeler
GB9315183D0 (en) Biosensors
AU121925S (en) Chess piece
ZA948591B (en) 6-oxo-nucleosides useful as immunosuppressants
IL105149A0 (en) Assembly for retaining keys or similar objects
GB9309004D0 (en) Staging
GB9318214D0 (en) Bearing arrangements
GB9325870D0 (en) Bearings
GB9326083D0 (en) Polypeptides which inhibit the nadph oxidase complex
GB9309190D0 (en) Bearing
GB9319041D0 (en) Bearing arrangement
ZA949525B (en) Enzyme inhibitors
GB9326629D0 (en) Enzyme composition
GB9324021D0 (en) Bearing
AU6177094A (en) Bath

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20011207